to

Gilbert Walker named editor in chief of Langmuir




to

Azafaros raises $28 million for lysosomal storage diseases




to

Innophos CEO exits with sale to private equity




to

Twist Bioscience to pay $22.5 million in settlement with Agilent

Deal will resolve dispute over DNA synthesis trade secrets allegedly brought to Twist from Agilent




to

Bayer outsources chemistry R&D to Nuvisan




to

Versalis to restart Italian cellulosic ethanol plant




to

University of Leeds lab taps DeepMatter for lab automation




to

Chemical Safety Board to require accident reporting




to

Straightforward path to linear alkylbenzenes identified

Nickel catalyst provides a route to the cleaning product chemicals with high yields and selectivity




to

Historic launches: A chemstronaut celebrated and Geoffrey Chaucer app-reciated




to

Could an NLRP3 inhibitor be the one drug to conquer common diseases?

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it




to

Investors chase sustainable aromatics

Processes using lignin, sugar, plastic waste, and more are moving out of the lab




to

Unusual monooxygenase mechanism adds oxygen to molecules without oxidizing them

Aminoperoxide adduct on the enzyme's cofactor leads to these nonoxidative oxygenation reactions




to

Diagnosing the novel coronavirus leads to trade offs

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans




to

Your skin microbiome can be used to predict your age

As we age, our skin changes, and so too do the bugs that live there




to

Biotech IPOs off to a strong start in 2020

4 firms have raised more than double their initial expectations




to

Chemists are finding their place on TikTok

Educators, researchers, and students are coming together to share chemistry demos and talk shop on the wildly popular video app




to

DSM to enter human milk oligosaccharide market by acquiring Glycom

$830 million deal builds on earlier moves into nutritional ingredients




to

ACS Career Days program brings career resources to the community

Society hosts professional development events in cities across the US




to

New Jersey town switches to peracetic acid wastewater treatment




to

Audentes to build gene therapy plant in North Carolina




to

Sabic to shutter Spanish polyether imide capacity




to

Wacker and Clariant to cut jobs




to

Women publish at rates equal to men but leave science earlier




to

Enzyme smooths path to planar chiral macrocycles

Good yields and enantioselectivity abide




to

Livestock producers look to antibiotic alternatives

Probiotics, sensors, and MOFs are among technologies that could keep herds healthy as industry turns away from antibiotics




to

45Q, the tax credit that's luring US companies to capture CO<sub>2</sub>

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash




to

Your guide to the ACS Spring 2020 National Meeting in Philadelphia

C&EN's editors pick the speakers and symposia to catch




to

Should the chemical industry have to prove it can pay for pollution cleanup?

No, US EPA says in proposal




to

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms previous concerns about health effects of chlorinated solvent




to

Groups sue US military to stop PFAS incineration

Activists say contracts with companies violate federal law




to

Sanofi to create new firm from its drug-making facilities

Venture will combine six active pharmaceutical ingredient production sites in Europe




to

Chemistry in Pictures: Tinsel town




to

Wonyong Choi to lead <i>ACS ES&T Engineering</i>

Inaugural editor in chief will focus on emerging and interdisciplinary areas of environmental engineering




to

How to make aziridines from olefins without expensive metals

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive, yet fleeting, oxaziridine intermediate




to

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




to

Biogen bets big on Sangamo's zinc fingers to treat Alzheimer's

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases




to

Faulty probes are to blame for CDC coronavirus testing woes

The tests can still be used, CDC says, as urgency over possible outbreak grows




to

C–H activation template opens door to less-accessible carbons

Multiple catalysts do complex chemistry to give a simple product




to

Thermo Fisher to buy molecular diagnostics firm Qiagen for $11.5 billion

Purchase brings the instrumentation giant into the fight against coronavirus




to

Groups sue US military to stop PFAS incineration

Activists say contracts with companies violate federal law




to

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms concerns about health effects of chlorinated solvent




to

Researchers grow thin 2-D insulator on large scale

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips




to

Faulty probes are to blame for CDC coronavirus testing woes

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits




to

US regulators take steps to boost hemp, CBD markets

USDA delays some requirements for growers, FDA seeks more data on cannabidiol products




to

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery




to

Julie Zimmerman named editor in chief of <i>Environmental Science and Technology</i>




to

Philip Proteau to helm <i>Journal of Natural Products</i>




to

Biogen to develop zinc finger therapies with Sangamo




to

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations